Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

MannKind (MNKD) and Tolero Pharmaceuticals announce a license agreement granting Tolero...

  • Monday, April 30, 2012, 8:48 AM ET
    MannKind (MNKD) and Tolero Pharmaceuticals announce a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MNKD's Bruton's tyrosine kinase program for the treatment of hematological malignancies and inflammatory diseases. MNKD +7.1% premarket.
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »